Department of Anesthesiology
Author [ Title(Asc)] Type Year
Filters: Author is Lien, Cynthia A  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
S
Naguib M, Kopman AF, Lien CA, Hunter JM, Lopez A, Brull SJ.  2010.  A survey of current management of neuromuscular block in the United States and Europe.. Anesth Analg. 111(1):110-9.
Pryor KO, Fahey TJ, Lien CA, Goldstein PA.  2004.  Surgical site infection and the routine use of perioperative hyperoxia in a general surgical population: a randomized controlled trial.. JAMA. 291(1):79-87.
Pryor KO, Lien CA, Fahey TJ, Goldstein PA.  2006.  Supplemental oxygen and risk of surgical wound infection.. JAMA. 295(14):1642;authorreply1642-3.
R
Lien CA.  2002.  Regional versus general anesthesia for hip surgery in older patients: does the choice affect patient outcome? J Am Geriatr Soc. 50(1):191-4.
P
Fleischut PM, Eskreis-Winkler JM, Gaber-Baylis LK, Giambrone GP, Wu X, Sun X, Lien CA, Faggiani SL, Dutton RP, Memtsoudis SG.  2016.  Provider Board Certification Status and Practice Patterns in Total Knee Arthroplasty.. Acad Med. 91(1):79-86.
Sun H, Culley DJ, Lien CA, Kitchener DL, Harman AE, Warner DO.  2015.  Predictors of performance on the Maintenance of Certification in Anesthesiology Program® (MOCA®) examination.. J Clin Anesth. 27(1):1-6.
Naguib M, Lien CA, Aker J, Eliazo R.  2004.  Posttetanic potentiation and fade in the response to tetanic and train-of-four stimulation during succinylcholine-induced block.. Anesth Analg. 98(6):1686-91,tableofcontents.
Kaullen JD, Owen JS, Brouwer KLR, Heerdt PM, Lien CA, Savarese JJ, Schmith VD.  2018.  Pharmacokinetic/Pharmacodynamic Model of CW002, an Investigational Intermediate Neuromuscular Blocking Agent, in Healthy Volunteers.. Anesthesiology. 128(6):1107-1116.
O
Bustillo MA, Lien CA, Mack PFogarty, Kopman DJ, Safavynia SA, Rubin L, Stein D, Härtl R, Stieg PE, R Hernandez N et al..  2018.  Optimizing patient access during an emergency while using intraoperative computed tomography.. World Neurosurg.
N
Lien CA.  2010.  Neostigmine: how much is necessary for patients who receive a nondepolarizing neuromuscular blocking agent? Anesthesiology. 112(1):16-8.
Lien CA.  2012.  A need to establish programs to detect and prevent drug diversion.. Mayo Clin Proc. 87(7):607-9.
G
Lien CA, Belmont MR, Heerdt PM.  2005.  GW280430A: pharmacodynamics and potential adverse effects.. Anesthesiology. 102(4):861-2;authorreply862-3.
F
Lien CA, Savard P, Belmont M, Sunaga H, Savarese JJ.  2009.  Fumarates: unique nondepolarizing neuromuscular blocking agents that are antagonized by cysteine.. J Crit Care. 24(1):50-7.
E
Suzuki T, Lien CA, Belmont MR, Tjan J, Savarese JJ.  2003.  Edrophonium effectively antagonizes neuromuscular block at the laryngeal adductors induced by rapacuronium, rocuronium and cisatracurium, but not mivacurium.. Can J Anaesth. 50(9):879-85.
D
Heerdt PM, Sunaga H, Owen JS, Murrell MT, Malhotra JK, Godfrey D, Steinkamp M, Savard P, Savarese JJ, Lien CA.  2016.  Dose-response and Cardiopulmonary Side Effects of the Novel Neuromuscular-blocking Drug CW002 in Man.. Anesthesiology. 125(6):1136-1143.
Mack PFogarty, Perrine K, Kobylarz E, Schwartz TH, Lien CA.  2004.  Dexmedetomidine and neurocognitive testing in awake craniotomy.. J Neurosurg Anesthesiol. 16(1):20-5.
C
Lien CA, Kopman AF.  2014.  Current recommendations for monitoring depth of neuromuscular blockade.. Curr Opin Anaesthesiol. 27(6):616-22.
Belmont MR, Lien CA, Tjan J, Bradley E, Stein B, Patel SS, Savarese JJ.  2004.  Clinical pharmacology of GW280430A in humans.. Anesthesiology. 100(4):768-73.